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Abstract
Background: Missing data can introduce bias in the results of randomised controlled trials (RCTs), but are typically
unavoidable in pragmatic clinical research, especially when patient reported outcome measures (PROMs) are used.
Traditionally applied to the composite PROMs score of multi-item instruments, some recent research suggests that
multiple imputation (MI) at the item level may be preferable under certain scenarios.
This paper presents practical guidance on the choice of MI models for handling missing PROMs data based on the
characteristics of the trial dataset. The comparative performance of complete cases analysis, which is commonly
used in the analysis of RCTs, is also considered.
Methods: Realistic missing at random data were simulated using follow-up data from an RCT considering three different
PROMs (Oxford Knee Score (OKS), EuroQoL 5 Dimensions 3 Levels (EQ-5D-3L), 12-item Short Form Survey (SF-12)). Data
were multiply imputed at the item (using ordinal logit and predicted mean matching models), sub-scale and score level;
unadjusted mean outcomes, as well as treatment effects from linear regression models were obtained for 1000
simulations. Performance was assessed by root mean square errors (RMSE) and mean absolute errors (MAE).
Results: Convergence problems were observed for MI at the item level. Performance generally improved with
increasing sample sizes and lower percentages of missing data. Imputation at the score and subscale level
outperformed imputation at the item level in small sample sizes (n ≤ 200). Imputation at the item level is
more accurate for high proportions of item-nonresponse. All methods provided similar results for large sample
sizes (≥500) in this particular case study.
Conclusions: Many factors, including the prevalence of missing data in the study, sample size, the number of
items within the PROM and numbers of levels within the individual items, and planned analyses need
consideration when choosing an imputation model for missing PROMs data.
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Background
Missing data can introduce bias in the results of rando-
mised controlled trials (RCTs), which can have a negative
impact on clinical decisions derived from them, and
ultimately patient care. Patient reported outcome mea-
sures (PROMs), which are increasingly used in RCTs as
primary or key secondary endpoints [1, 2], can be particu-
larly susceptible to containing missing data, either due to
unasnwered or incomplete questionnaires [3, 4]. PROMs
are carefully designed and validated instruments, often in
questionnaire form, intended to capture information on
health status from the patients’ perspective [5–7]. The
majority of PROMs consists of several questions, or items,
and are hence referred to as multi-item PROMs. The
PROMs items are usually combined into one composite
score and/or subscales. Missing data in multi-item
PROMs can occur either in the form of unit-nonresponse,
where all items have been left unanswered [8], or
item-nonresponse, where responses to the PROM are
incomplete [9]. Missing data can affect the calculation of
the composite score and/or subscales. Some scoring man-
uals allow for small amounts of missing items, while other
scoring manuals do not facilitate the calculation of com-
posite scores in the presence of any missing items.
Traditionally, research concerning missing data in
PROMs has focussed on how the missing PROMs com-
posite scores should be handled, with multiple imput-
ation (MI) methods considered to be one of the most
reliable methods [10–12], although MI is not commonly
implemented in the analysis of RCT data [13–16]. How-
ever, for multi-item PROMs, different imputation ap-
proaches are possible, e.g. imputation at the composite
score, subscale (where available) or items level. Imput-
ation at the item or subscale level may yield additional
information and therefore improve the accuracy of such
imputations.
Research has not commonly been performed on the
comparison between these approaches. Work by Simons
et al. [17] compared imputation at the item and compos-
ite score level for estimating EuroQoL 5 Dimensions 3
Levels (EQ-5D-3L) composite scores in the presence of
missing at random (MAR) data. The authors found that
both approaches performed similarly in terms of accur-
acy for larger data sets (n > 500) and where missing data
primarily followed a unit-nonresponse pattern for all
different proportions of missing data investigated (i.e. 5–
40% of missing data). As the sample size was decreased
to 500 observations or fewer, both approaches
performed similarly for up to 10% of missing data, how-
ever, MI at the composite score level was found to be
more accurate for 20 and 40% of missing data within these
smaller sample sizes. MI at the item level was found to be
performing better as the proportion of item-nonresponse
increased. The authors recommended further research to
assess generalisability of their findings to other PROMS
with potentially different psychometric properties.
Eekhout et al. [18] compared a number of different
methods to account for missing data in the Pain Coping
Inventory (PCI), a 12-item PROM. In their work, the
PCI was used as a covariate in a regression model, and
the different MI approaches were compared in terms of
accuracy and precision of the fitted PCI regression coef-
ficients. In this scenario, MI at the item level achieved
the best results, while MI applied to the composite
scores resulted in overestimated standard errors where
large percentages (> 50%) of participants had missing
data. The authors also found that complete cases ana-
lysis (CCA), which does not impute missing data, yielded
acceptable results in terms of regression coefficients.
However, standard errors were overestimated, especially
when more than 10% of the study population had some
missing PROMs data, and therefore the authors advised
against the use of CCA. However, other research has
suggested that CCA may be appropriate for the analysis
of RCTs under specific circumstances, i.e. when missing
data is limited to a single outcome and if the variables in
the MAR mechanism are included in the covariates in
the analysis model [19].
Hypotheses for this work
The composite scores, and subscales where applicable,
for many multi-item PROMs are calculated as the
unweighted [20] or weighted [11, 12] sum of the items.
Generally, composite scores cannot be derived if at least
one item is missing, although some scoring manuals
allow for a small number of items to be substituted by
the mean score of the available items [20, 21].
All items contribute to the calculation of the compos-
ite scores. Therefore, we hypothesise, similarly to Simons
et al. [17], that where the MAR data follow an
item-nonresponse pattern, imputation at the item level is
superior to that at the composite score or subscale level,
particularly as the proportion of item-nonresponse
increases, as the latter approaches disregard some of the
available data. Correspondingly, we hypothesise that
where the MAR data follow primarily a unit-nonresponse
pattern, all MI approaches perform similarly, as in this
scenario the MI at the item level cannot utilise any add-
itional information that is not available to the MI at the
composite score or subscale level. Where validated sub-
scales exist for a PROM, we hypothesise that there are
benefits in terms of accuracy when imputing at the sub-
scale level compared to imputing at the composite score
level, given sufficient data is available to calculate at least
one of the subscales. No benefit of applying MI at the sub-
scale level over MI at the composite score level is ex-
pected in unit-nonresponse scenarios, or where neither of
the subscales can be estimated due to missing data.
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CCA is expected to perform similarly to MI at the
composite score level under MAR for appropriately ad-
justed analysis models, i.e. where the covariates include
the key components of the MAR mechanism [19].
Aims of this research
This research aims to compare different MI approaches
for handling missing PROMs data, i.e. imputation at
the composite score, subscale (where appropriate) or
item level, while also exploring the benefits and disad-
vantages of these approaches. A variety of different
MAR patterns, sample sizes and proportions of missing
data are explored using simulation studies using three
widely used PROMs. Performance of the different im-
putation approaches in terms for producing composite
scores and adjusted treatment effects are considered,
together with the performance of CCA for the gener-
ation of treatment effects. This research aims to valid-
ate previous findings in a different dataset, and to
expand this research to additional PROMs. This work
will generate clearer guidelines for the appropriate
handling of missing PROMs endpoints, specifically with
regards to the use of MI.
Methods
Design of the simulation exercise
An overview of the simulation study is provided in Fig. 1.
Simulations started with a complete dataset of the relevant
sample size. A pre-specified proportion of MAR data was
then introduced in the PROMs data at follow-up. MI was
performed at the composite score, subscale (where applic-
able) and item level. Estimates of the mean composite
scores, treatment effects and corresponding standard
errors (SE) were obtained from the complete dataset (i.e.
the ‘true’ estimates) and the different MI approaches. In
addition, the treatment effect was also estimated from the
dataset with imposed missing data using a CCA, i.e. an
analysis that excludes all participants with missing out-
come data. The treatment effects were estimated using a
regression model with the relevant composite PROMs
score as the outcome variable adjusting for baseline com-
posite scores, randomisation allocation, age and sex [22].
This simulation study aimed to obtain 1000 independ-
ent iterations for which the imputation models success-
fully converged (i.e. 1000 valid imputation results) for
each scenario. Where imputation models did not
converge, additional iterations were run (up to a max-
imum of 11,000 iterations per scenario).
The parameters of interest in this simulation study are
the mean composite outcome scores and the average
treatment effect. The performance parameters used in
this study were root mean square errors (RMSE), mean
absolute errors (MAE – shown in Additional file 1).
The simulation work was performed in StataSE 14
[23], and the mi impute and mi estimate commands
were used.
Case study
This simulation study was based on data collected
within the Knee Arthroplasty Trial (KAT) [22, 24].
KAT is a large multi-centre RCT considering the clin-
ical and cost effectiveness of new developments in
knee replacements. KAT was designed as a partial factor-
ial, pragmatic trial, with participants being randomised to
at least one of four different comparisons. In this simula-
tion study, only one of the comparisons is considered, i.e.
patellar resurfacing vs. no patellar resurfacing. Long-term
follow-up beyond 10 years is ongoing for KAT. Here, data
for a single follow-up time point at 5 years post random-
isation were considered, and only participants with fully
observed baseline and outcome data were included in the
simulation study.
Fig. 1 Design of the simulation study. MAR – missing at random, MI – multiple imputation, SE – standard error, RMSE – root mean square error,
MAR – mean absolute error
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A total of 1715 participants were randomised to the
patellar resurfacing vs. no patellar resurfacing comparison.
In this simulation study, the 11% of participants known to
have died before the 5 year follow-up were excluded. Of
the 1526 remaining participants, 5 year follow-up data for
the Oxford Knee Score (OKS), EQ-5D-3L and 12 item
Short Form Survey (SF-12) were unavailable for 17, 18
and 33%, respectively, with missing data rates similar in
both treatment arms. The OKS can be calculated for up
to two missing items, and there are additional participants
(approximately 7%) for whom one or two items are miss-
ing. One thousand four hundred twenty-two participants
were eligible to complete version 2 of the SF-12. The
remaining 104 participants completed version 1 of the
SF-12 at a minimum of one point in the trial and were not
included in these summaries.
Correlations between the PROMs (composite scores,
subscales and items) and the baseline data to be used in
the imputation and analysis modes are shown in the
Additional file 1. The correlations are low to moderate,
which is common in RCT datasets.
Instruments
The 5-year follow-up data for three patient reported out-
come measures is used, namely:
 The Oxford Knee Score (OKS): an instrument
designed to assess outcomes following a knee
replacement in RCTs [25, 26]. It consists of 12 five-
level items, and the composite score ranges from 0
to 48. The OKS can be divided into validated pain
and function subscales [20]. Higher scores indicate
better outcomes.
 The SF-12: a 12-item generic health measure [27, 28].
The SF-12 generates two subscales, the physical
component summary score (PCS) and the mental
health component summary score (MCS). Both
subscales are standardised to have a mean of 50 with
a standard deviation of 10 [29]. As the calculations for
both the MSC and PCS utilise all items, rather than
just a subset, they are referred to as ‘composite scores’
subsequently for consistency. Higher scores indicate
better outcomes.
 EQ-5D-3L: a utility questionnaire assessing
participants’ health state based on their mobility,
self-care, usual activities, pain/discomfort and anx-
iety/depression [30]. Scores of 1 indicate full health,
0 indicates a health state equal to death, and scores
lower than 0 indicate health states worse than death.
Missing data simulation
Missing data were introduced in a subset of participants
with completely observed data for their PROMs outcomes
and relevant baseline data (N = 1030 for the OKS, N = 1160
for the EQ-5D-3L and N = 797 for the SF-12 MCS and
PCS – i.e. the ‘base cases’). The simulated missing data pat-
terns mirrored those most commonly observed at the se-
lected follow-up for the three PROMs, which followed
predominantly a unit-nonresponse pattern (Table 1).
For the OKS, additional missing data patterns were simu-
lated, i.e. a scenario where all missing data was due to
unit-nonresponse, as well as a scenario where 70% of the
missing data were due to item-missingness. MAR data
was simulated using an algorithm by van Buuren et al.
[31] and also outlined in publications by Yu et al. [32] and
Simons et al. [17]. This algorithm allows researchers to
vary the missing data patterns, as well as the percentage of
Table 1 Missing data patterns simulated for each PROM













Unit-nonresponse 73.1% Unit-nonresponse 56.1% Unit-nonresponse 87.9%
Only item 7
missing
15.6% Only item 2b missing 20.3% Only item 5 missing 5.1%
Only item 4
missing
3.3% Only item 4b missing 6.5% Only item 1 missing 2.6%
Only item 6
missing
2.7% Items 2b and 3b
missing
4.5% Only item 4 missing 1.8%
Only item 9
missing
2.1% Only item 3b missing 4.0% Only item 3 missing 1.5%
Only item 10
missing
1.5% Items 2b, 3b and 4b
missing
3.5% Only item 2 missing 1.1%
Only item 1
missing
0.9% Items 2b and 4b
missing
3.3% n/a Other patterns occurred too




0.9% Only item 6c missing 1.8% n/a
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participants with missing data; implementation followed
the steps outlined in Fig. 2. Missing data were generated
for 5, 10, 20 and 40% of participants. Sample sizes of 100,
200, 500 and the maximum sample available were consid-
ered in this simulation work. Smaller sample sizes were
obtained by sampling the required number of participants
from the full dataset without replacement prior to the
simulation of missing data.
Variables included in the algorithm to generate MAR
data were treatment allocation, age, baseline PROMs
score, height, ASA Grade (American Society of Anesthesi-
ologists physical status classification system) and size of
the recruiting centre (< 30, 30–100, > 100 participants).
Implementation of the MI models
All imputation models were implemented using an MI by
chained equations (MICE) approach [33]. MI models to
handle missing continuous data (i.e. composite scores and
subscales) were based on linear regression models, using a
predicted mean matching (PMM) approach. Imputations
at the item level were implemented as ordered logistic re-
gression models and also as regression models (using
PMM), treating the items as continuous variables. Covari-
ates used in all MI models included the baseline compos-
ite PROM score, as well as all variables used in the
analysis model and those used in the simulation of MAR
data. For the OKS simulations, MI models at the subscale
and item level also included the baseline values of the
subscales.
Imputations were performed separately by randomised
treatment, where feasible [19]. This approach allows fac-
tors such as the distribution of outcomes, their variance
and relationship with any of the covariates to differ
between treatment arms. If model convergence was low,
imputations included the randomised treatment as a
covariate instead. The number of imputations was 50 for
all imputations at the composite score and subscale
level. For MI at the item level and simulations reprodu-
cing the observed missing data patterns, 50 imputations
were run for the base cases, and imputations equal to
the percentage of missing data were used for smaller
sample size [33], while 10 imputations were used for
exploratory scenarios.
The MI models at the item level were complex, and
convergence issues have been demonstrated [17]. There-
fore, imputations at the item level were run one-by-one
(i.e. using the add(1) option in Stata’s mi impute com-
mand), which ensured that additional imputations con-
tinued to be generated after one out of the required
imputations failed. We allowed for up to 50% of the re-
quired imputations to fail to converge before an iteration
of the item level imputation simulation was classed as
having failed.
After the presentation of the simulation results, the
different imputation approaches were applied to a case
study to examine how they affected the interpretation of
the trial. This example included a random subset of 200
participants, with missing data imposed as described
above for approximately 20% of participants.
Results
Feasibility of the MI approaches
Imputations at the composite score and subscale level
were feasible in all simulation scenarios. However, conver-
gence failures were observed for almost all scenarios at
the item level using the ologit approach; instances of
non-convergence increased markedly for decreasing sam-
ple sizes and increasing proportions of missing data
(Table 2). For this reason, item-level imputations for the
OKS and SF-12 were not run separately by treatment arm
as a compromise. Considerations for this approach are
discussed later. Scenarios with fewer than 1000 valid im-
putations at the item level were not included in subse-
quent comparisons, e.g. insufficient valid results were
Fig. 2 Depiction of the algorithm used for each iteration simulation
of missing PROMs data within the complete cases dataset
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obtained for MI at the item level for 10% or more missing
data for sample sizes of 100, and for the combination of
40% of missing data and a sample size of 200.
Some instances of non-convergence were also ob-
served for small sample sizes for imputation at the item
level using the PMM approach.
Performance of the different imputation approaches and
CCA
Generally, RMSE (and MAE; see Additional file 1) in-
creased with increasing percentages of missing data, as
well as with decreasing sample size.
OKS with observed missing data pattern
Figure 3 shows the RMSE in the estimated OKS com-
posite scores after applying the different MI approaches
to datasets covering a range of sample sizes and propor-
tions of participants with missing PROMs data following
the observed missing data pattern.
RMSE for MI at the composite score level was almost
identical to the RMSE for MI at the subscale level.
Higher levels of the RMSE were observed for MI at the
item level (both the ordinal logit and PMM approach)
for higher proportions of missing data and smaller sam-
ple sizes. The SEs for these composite score estimates
were larger than the true SE for scenarios with 20 and
40% of MAR data for all imputation approaches (Fig. 4).
Figure 5 presents the RMSE in the treatment effect esti-
mates using the imputed OKS composite scores as the
outcome variable in the regression model. All MI ap-
proaches and CCA performed very similarly. As above, the
SE for these estimates was marginally increased compared
to the true SE for scenarios of 20% or more MAR data.
Considering other missing data patterns for the OKS
Under a unit-nonresponse scenario, the RMSE observed in
the composite scores estimates was similar for all imput-
ation at the composite score, subscale and item level using
the ologit approach, except for small sample sizes and 40%
of missing data, where performance of the item level MI
was marginally worse (Fig. 6). Imputation at the item level
using a PMM approach performed worse. MI approaches
and the CCA performed similarly in terms of bias observed
in the treatment effects, except for imputation at the
item level using a PMM approach, which had higher
RMSEs for larger proportions of missing data.
When the item-nonresponse was increased to 70%, all
approaches performed similarly for large sample sizes. Item
imputation (both ologit and PMM approaches) performed
worse than its comparators for small sample sizes when
composite scores were estimated (Fig. 7). Considering the
estimates of the treatment effects, imputation at the item
and subscale level offered a marginal benefit over imput-
ation at the composite score level and CCA in terms of the
performance measure observed in the treatment effects for
large proportions of missing data (20% or more), as seen in
Fig. 8. The different approaches of handling missing data
performed similarly for smaller proportions of missing data.















100 5 88.2% 89.7% 88.0% 91.9%* 72.1%
10 95.6%* 95.3%* 94.1%* 98.2%* 83.8%
20 99.8%* 99.6%* 99.1%* 99.9%* 94.4%*
40 100%* 100%* 100%* 100%* 99.9%*
200 5 40.1% 22.7% 35.4% 52.1% 19.9%
10 50.8% 25.2% 45.6% 69.6% 25.5%
20 64.5% 32.1% 57.0% 87.2% 45.30%
40 99.7%* 60.0% 78.4% 99.3%* 85.6%
500 5 21.6% 8.84% 20.0% 3.5% 11.2%
10 24.9% 9.3% 23.4% 6.3% 14.2%
20 27.8% 11.0% 27.5% 12.8% 17.3%
40 41.4% 16.0% 28.6% 34.7% 23.6%
Full
samplea
5 1.0% 0% 0.7% 0% 0.3%
10 3.9% 0.1% 1.6% 0.2% 1.86%
20 12.5% 0.4% 5.2% 1.1% 6.8%
40 28.0% 3.8% 10.4% 8.4% 17.4%
*For scenarios highlighted *, 1000 valid simulations could not be obtained, and these scenarios are not included in subsequent summaries
aThe full sample includes 1030 observation for the OKS simulation, 797 for the SF-12 and 1160 for the EQ-5D-3L
Rombach et al. BMC Medical Research Methodology  (2018) 18:87 Page 6 of 16
SF-12 simulation results
Simulated missing data in the SF-12 was due to item
missingness for almost 45% of participants. RMSEs
observed in the physical component summary score
(PCS) were very similar for imputations at the com-
posite score and item-level imputation (ordinal logit),
but higher for the item level imputation using the
PMM approach. For the mental health component
summary score (MCS), higher RMSEs were produced
by MI at the item level (ologit approach), for combi-
nations of higher proportions of missing data and
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Sample size of the simulation dataset
40% MAR
Score MI Subscale MI Item MI (PMM)
Item MI (ologit) True SE
Fig. 4 SE in the OKS composite score estimates (observed missing data pattern). Abbreviations: MAR – Missing at random; MI – Multiple
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Sample size of the simulation dataset
40% MAR
Score MI Subscale MI
Item MI (PMM) Item MI (ologit)
Fig. 3 RMSE in the OKS composite score estimates (observed missing data patterns). Abbreviations: MAR – Missing at random; MI – Multiple
imputation; OKS – Oxford knee score; PMM – Predicted mean matching; RMSE – Root mean square error
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observed otherwise. Imputation at the item level using
the PMM approach produced higher RMSEs for
higher proportions of missing data.
RMSEs observed in the treatment effects were marginally
lower when item imputation was used for combinations of
larger proportions of missing data. MI at the composite
score level and CCA performed similarly (Fig. 10 –shown
for the PCS).
All approaches to handling missing data resulted in
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Sample size of the simulation dataset
40% MAR
Score MI Subscale MI Item MI (PMM)
Item MI (ordinal logit) CCA
Fig. 5 RMSE in the treatment effect estimates using the imputed OKS composite scores as the outcome variable in the regression model
(observed missing data pattern). Abbreviations: CCA – Complete cases analysis; MAR – Missing at random; MI – Multiple imputation; OKS – Oxford
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Sample size of the simulation dataset
40% MAR
Score MI Subscale MI
Item MI (PMM) Item MI (ologit)
Fig. 6 RMSE in the OKS composite score estimates (unit-nonresponse). Abbreviations: MAR – Missing at random; MI – Multiple imputation; OKS – Oxford
knee score; PMM – Predicted mean matching; RMSE – Root mean square error
Rombach et al. BMC Medical Research Methodology  (2018) 18:87 Page 8 of 16
EQ-5D-3L simulation results
Almost 88% of the missing EQ-5D-3L data were due to
unit-nonresponse. Considering estimates of the compos-
ite scores (Fig. 11), imputation at the composite score
level and at the item level using the PMM approach
performed similarly. Imputation at the item level using
the ologit approach performed worse for combinations
of large proportions of missing data and smaller sample
sizes. A similar trend was observed for the estimated
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Sample size of the simulation dataset
40% MAR
Score MI Subscale MI
Item MI (PMM) Item MI (ologit)
Fig. 7 RMSE in the OKS composite score estimates (70% item-nonresponse simulations). Abbreviations: MAR – Missing at random; MI – Multiple
























0 200 400 600 800 1000

























0 200 400 600 800 1000

























0 200 400 600 800 1000

























0 200 400 600 800 1000
Sample size of the simulation dataset
40% MAR
Score MI Subscale MI Item MI (PMM)
Item MI (ologit) CCA
Fig. 8 RMSE in the treatment coefficient estimates using the imputed OKS composite scores as the outcome variable in the regression model
(70% item-nonresponse). Abbreviations: CCA – Complete cases analysis; MAR – Missing at random; MI – Multiple imputation; OKS – Oxford knee
score; PMM – Predicted mean matching; RMSE – Root mean square error
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Sample size of the simulation dataset
40% MAR
Score MI Item MI (PMM)
Item MI (ordinal logit)
Fig. 9 RMSE in the MCS composite score estimates. Abbreviations: MAR – Missing at random; MI – Multiple imputation; MCS – SF-12 Mental
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Sample size of the simulation dataset
40% MAR
Score MI Item MI (PMM)
Item MI (ordinal logit) CCA
Fig. 10 RMSE in the treatment coefficient estimates using the imputed PCS composite scores as the outcome variable in the regression model.
Abbreviations: CCA – Complete cases analysis; MAR – Missing at random; MI – Multiple imputation; PCS – SF-12 Physical component summary
score; PMM – Predicted mean matching; RMSE – Root mean square error
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Sample size of the simulation dataset
40% MAR
Score MI Item MI (PMM)
Item MI (ordinal logit)
Fig. 11 RMSE in the EQ-5D-3L composite score estimates. Abbreviations: EQ-5D-3L - EuroQol 5 dimension 3-level questionnaire; MAR – Missing at





























0 200 400 600 800 1000 1200





























0 200 400 600 800 1000 1200





























0 200 400 600 800 1000 1200





























0 200 400 600 800 1000 1200
Sample size of the simulation dataset
40% MAR
Score MI Item MI (PMM)
Item MI (ordinal logit) CCA
Fig. 12 RMSE in the treatment coefficient estimates using the imputed EQ-5D-3L composite scores as the outcome variable in the regression model.
Abbreviations: CCA – Complete cases analysis; EQ-5D-3L - EuroQol 5 dimension 3-level questionnaire; MAR – Missing at random; MI – Multiple
imputation; PMM – Predicted mean matching; RMSE – Root mean square error
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the RMSE between the item level imputation using the
ologit approache and the other imputation approaches
were less pronounced. The CCA performed similarly to MI
at the composite score level. All approaches performed
similarly for large sample sizes.
Additional results using the MAE confirmed the findings
reported here and can be accessed in the Additional file 1.
Application of the different imputation approaches to a
case study
The case study includes 200 participants, equally split
between the treatment arms, with 17% of participants
having missing OKS outcome data. The estimates of the
treatment effect are displayed in Table 3. The data shows
that the estimates produced from the imputation at the
item level (ologit) are most similar to the CCA, while
the treatment effect from the imputation at the item
level using the PMM approach, subscale and composite
levels are very similar, and slightly lower than the
estimates produced by the other approaches. However,
in this case, all analyses approaches lead to the same
conclusion, i.e. that there is insufficient evidence to sug-
gest a statistically significant difference in OKS out-
comes between the trial arms.
Discussion
PROMs are commonly used in clinical research, but can
be prone to missing data. Analytical methods to limit
the potential bias introduced by missing data are widely
discussed in the current literature, with MI considered
to be one of the most appropriate methods to handle
missing data. In this simulation work, MI was not shown
to perform significantly better than CCA in estimating
treatment effects, in line with the literature [22]. How-
ever, this is due to the fact that the variables in the ana-
lysis model were also very influential in the algorithm
generating the MAR data. In reality, it is likely that the
MAR mechanism will be related to more variables out-
side the analysis model, and hence MI may be preferable
to CCA due to its ability to account for complex MAR
mechanisms.
When implementing MI, there is little guidance on
whether imputation should be applied at the composite
score, subscale or item level. This simulation work has
shown that MI at the item level may not be feasible for
small sample sizes, particularly as the number of
PROMS items increases. However, where feasible, it can
have advantages over imputation at the composite score
level, or subscale level, where applicable, in term of
accuracy of the statistical output or facilitation of subse-
quent analyses. Arguably, the differences in performance
for the imputation approaches were relatively small, e.g.
up to one point on the OKS, which ranges from 0 to 48,
and small differences in the estimated treatment effects,
as shown in the case study. These differences lie within
the measurement error of the PROM, and do not exceed
the minimal important difference, which are estimated
to be four points or five points [34]. However, many tri-
als aim to detect small effect sizes; i.e. the KAT study
was powered to detect a difference of 1.5 points in the
OKS (patella resurfacing comparison) [22]. Therefore,
even these moderate differences could affect trial con-
clusions, and the choice of MI approach hence needs to
be considered carefully, taking into account a multitude
of factors:
Sample size, proportion of missing data and missing data
patterns
The different imputation approaches yielded similar
results for large sample sizes, as well as smaller sample
sizes with 10% missing data or less, except for simula-
tions with high proportions of item-nonresponse, where
imputation at the item or subscale level (OKS) may be
advantageous. For smaller samples with large amounts
of missing data, imputation at the composite score level
is likely to be more beneficial in scenarios with a pre-
dominantly unit-nonresponse pattern, in line with previ-
ous research [17]. Imputation at the item or subscale
level (where available) becomes more beneficial with
increasing amounts of item-nonresponse.
Generally, imputation at the item level may not be
feasible for scenarios with small sample sizes.
Feasibility of the imputation model
Item-level imputation models are complex, and may not
be feasible for small sample sizes and/or larger propor-
tions of missing data, and the issue of non-convergence
becomes increasingly prominent with increasing amounts
of items to be imputed, and lower counts in some of the
item levels. Using treatment as an explanatory variable in
Table 3 Impact of the different analysis approaches on the trial conclusion
Analysis approach Treatment effect (95% CI) Number of participants included
Complete cases analysis 0.9 (−2.6, 4.4) 167
MI at the composite score level 0.7 (−2.8, 4.2) 200
MI at the subscale level 0.7 (− 2.7, 4.1) 200
MI at the item level (ologit) 0.9 (−2.5, 4.3) 200
MI at the item level (PMM) 0.6 (−2.7, 3.9) 200
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the MI model instead of running imputations separately
by treatment arm may enable convergence of complex im-
putation models at the item level when imputing using
ordinal logit models for the PROM items. However, this
approach is not in line with current guidance and its
appropriateness is dependent on distributional assump-
tions [19, 35], which need to be assessed on a case-by-case
basis. The approach was used in this simulation study as a
compromise to achieve higher convergence rates, and jus-
tifiable because the distribution of outcomes, their vari-
ance and relationship with other covariates was assumed
to be the same across treatment arms. However, re-
searchers should bear in mind that this assumption may
not hold for other datasets.
Non-convergence of the item imputation using ordinal
logit models was caused by perfect prediction, due to
very low numbers of observations in one or more of the
levels in one of the items to be imputed. Therefore, be-
fore attempting imputation at the item level using or-
dinal logit models, the dataset should be investigated
thoroughly for low count and potential problems due to
perfect prediction. Even if there is no perfect prediction
in the data for the imputation model for a specific item,
low counts may still result in unreliable estimates and
standard errors to be produced by the statistical models,
which are likely to lead to bias in the MI estimates.
Therefore, ahead of implementing imputation models,
each statistical model to be used in the imputation
should be run individually, and separately (by treatment
arm if imputations are to be run this way), to confirm
that appropriate estimates can be produced.
For combinations of small sample sizes and larger pro-
portions of missing data, problems were also observed
for imputation at the item level were a regression model
using PMM was used to impute missing data. These is-
sues were related to overfitting of the model, i.e. the use
of too many covariates for small amounts of data. Again,
the individual statistical models should be checked
ahead of implementing any imputation models.
Planned analysis
While the different imputation approaches may not offer
distinct benefits in terms of reducing the RMSE and
MAR in some circumstances, there may still be situa-
tions where imputation at the item or subscale level is
advantageous. This is true where the planned analysis in-
cludes not only the analysis of the composite scores,
but also of the subscales (where applicable) or even
the PROMs items. If feasible, imputation at the item
or subscale level ensures that a common imputation
dataset can be used for all analyses related to the
relevant PROM.
Overall, performance of the analysis approaches
decreased with increasing proportions of missing data,
emphasising the importance of preventing the occur-
rence of missing data prospectively [36].
Strengths and limitations
This research contributes to the literature in that it uses
new datasets to validate previous work on the effect MI
at the item and composite score level on the RMSE and
MAR observed in the composite scores [17] and treat-
ment effects [18] in PROMS analysis to different data-
sets and patient populations. In addition, previous
research has been extended to additional questionnaires,
and additional missing data scenarios, thus offering add-
itional guidance to researchers faced with missing PROMs
data in RCTs. This study covers a range of sample sizes
(100 to approximately 1000) and rates of missing data (5,
10, 20 and 40%), which are representative of current fig-
ures observed in published RCTs [14–16, 37, 38]. While
RCTs with lower sample sizes are also common, these are
often pilot and feasibility studies which focus on endpoints
such as recruitment and completeness of endpoints, or
are underpowered for the type of analyses used in this
simulation study.
Although every effort was made to conduct this simu-
lation study as thoroughly and completely as possible, it
is not without limitations. Scenarios considered are lim-
ited to specific sample sizes, proportions of missing data
and missing data patterns. However, we believe that
sample sizes between 100 to around 1000 participants,
and missing data levels between 5 and 40% are represen-
tative for the vast majority of RCTs. Future work on lar-
ger sample sizes, expanding the generalisability to
larger-scale epidemiological research, is needed. These
studies often collect a larger pool of patient demograph-
ics, the inclusion of which may affect the performance of
the imputation models. Similarly, the missing data pat-
terns used were based on those observed in the KAT
trial. It is believed that these patterns are realistic and
representative for the PROMs used, and we included
variations in the amount of unit-nonresponse for the
OKS simulations.
This simulation work is restricted to the KAT dataset.
Additional validation work in further datasets, other dis-
ease areas, as well as PROMs may be useful to explore if
the recommendations provided here still hold when the
different approaches are applied to datasets with differ-
ent correlations between baseline and outcome data,
distributions of outcomes, different treatment mecha-
nisms and different MAR patterns. However, the fact
that findings by Simons et al. [17] and Eekhout et al.
[18] could be replicated indicates that findings are gen-
eralisable. The main body of this simulation work used
the missing data pattern observed in the KAT study at the
5-year follow-up. Additional missing data patterns (i.e. unit-
nonresponse and increased levels of item missingness)
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were only considered for the OKS, in order to supplement
the findings by Simons et al. [17] on the effect of increased
proportions of unit-nonresponse in the EQ-5D-3L.
Findings are limited to PROMs with up to 12 items.
Therefore, uncertainty still exists as to the maximum
number of items within a PROM for which item imput-
ation would still be considered feasible, which is likely to
be related to both the construct of the PROM, as well as
the sample size. However, we believe that larger datasets
are needed to ensure feasibility of item imputation for
PROMs with more than 12 items, which are therefore
not within the remit of this research.
In this simulation work, the relative performance of
the imputation approaches appeared to be related to the
outcome of interest, with smaller differences for the esti-
mation of the treatment effect compared to the estima-
tion of the composite scores across all scenarios. Further
research is needed to establish if this is an artefact of
these parameters being estimated on different scales (i.e.
the OKS ranges from 0 to 48, while the treatment effects
observed in the trial were nonsignificant and close to
zero), or whether this is a more generalisable finding.
This study only considers analysis scenarios with a sin-
gle follow-up time point. This approach was chosen be-
cause the primary analyses of many trials focus on the
primary endpoint at a specific follow-up time point, ra-
ther than analyses approaches that take into account the
longitudinal data. Imputation of PROMs item level data
at additional time points was ruled out as infeasible due
to the low convergence rates already observed in the
current scenarios. While including in the item level im-
putation model of PROMs follow-up data at intermedi-
ate time points may have improved imputations at the
five-year follow-up, in practice this data is often less well
collected at the outcome data at the primary follow-up
time point. This leads to additional complexity of the
imputation models, and was therefore not included in
this study. Researchers should examine on a
case-by-case basis if sufficient intermediate or later
follow-up data is available to benefit the imputation of
missing outcome data.
Missing not at random (MNAR) mechanism and mis-
specification of MI models were not considered in this
paper, although Simons et al. [17] reported benefits of
MI at the item level over MI at the score level for the
latter scenario. However, it was felt that MI levels could
be misspecified in a number of ways, and that the results
from selected misspecifications may not be generalisable.
This is because some variables are much more predictive
of the missing data than others. The same applies to
MNAR scenarios, which could be considered as misspe-
cified MI models, as they are unable to account for im-
portant factors that are predictive of data being missing
as well as the missing observations themselves. We
recommend that MNAR analyses are best addressed as
part of a sensitivity analysis [39–41].
Some of the non-convergence rates observed in the re-
sults are very high, and could have been improved by
simplifying the MI models. However, MI models were
constructed using the full base case datasets, and were
then applied to all sample size scenarios to allow a direct
comparison of performance between the different sce-
narios. In reality, MI models should be generated based
on the dataset under consideration, and should adjust
their complexity based on the type and quantity of data
available, and ensure that relevant variables that are good
predictors of data being missing, and/or the variables to
be imputed, as well as that the functional form of the im-
putation model is appropriate for the data. Here, the cor-
relations between outcomes and the covariates used in the
imputation models were low to moderate. While this is
representative of RCTs in general, the inclusion of more
highly correlated variables will improve imputation re-
sults. Researchers should also run all required imputations
within the same model. The approach chosen in this
simulation study, whereby item level imputations were
run one-by-one to exclude occasional instances of
non-converges was chosen as a compromise to increase
convergence rates within these simulations.
The high failure rates in some of the simulations may
have resulted in a systematic selection bias being ob-
served for the results of the relevant simulation scenar-
ios, due to item MI being more likely to fail in datasets
with certain characteristics. MI at the item level is con-
sidered less likely to be feasible in these scenarios, which
were typically those with smaller sample sizes and higher
missing data rates. More likely, however, is that for the
smaller sample sizes, the ordinal logit models used in
the item regression are of suboptimal fit to produce reli-
able prediction to inform the imputations. For this rea-
son, imputation at the composite score or subscale level
is recommended for these scenarios. Simulations with
higher convergence rates are not thought to be affected.
Different numbers of imputations were used for the im-
putations at the item level, mainly for practical reasons in-
cluding time taken to perform large numbers of the
imputations at this level, and were therefore inconsistent
across some of the scenarios. The number of imputations
performed were still in line with available guidance, and
are therefore expected to produce robust results. However,
it may be possible that the differences in the number of
imputations has added some variation to the study results.
Finally, simulations were restricted to 1000 iterations,
again mainly for practical reasons including time taken
to perform large numbers of the imputations at the item
level. Additional simulations (up to 5000) were run for
isolated scenarios, and results were consistent with those
presented in this paper.
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Conclusions
We concluded that the differences between the imput-
ation at the item/subscale level and the imputation at the
composite score level are likely to be small across realistic
settings in studies with incomplete patient-reported
outcome measures.
In idealistic settings, the imputation at the item/subscale
level may provide more precise estimates of treatment ef-
fect compared to the imputation at the composite score
level or CCA, because it better captures the correlation
amongst the different items.
However, both the case study and simulations sug-
gested that the imputation at the item/subscale level is
often infeasible and prone to convergence (perfect pre-
diction) issues, and hence unlikely to be an appropriate
method for imputing missing PROMs across more real-
istic circumstances.
Choosing an appropriate MI approach can help ensure
the trial reports accurate estimates of treatment effects
in the presence of missing data. However, better analyt-
ical approaches for handling missing data do not reduce
the importance of taking active steps to minimising the
occurrence of missing data at the trial’s design and
follow-up stages. Appropriate sensitivity analysis to
assess the impact of missing data on the trial results
when changing the underlying assumptions about the
missing data mechanism also remains imperative.
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